Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strepsils for prevention of post-extubation sore throat after ERCP
PACTR202409618171064Phase 0Completed
- Sponsor
- Mansoura University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of amylmetacresol + 2,4-dichlorobenzyl alcohol in pharyngitis, cough and dysphonia (2 arms), sponsored by Mansoura University. Primary endpoint: Incidence and severity of sore throat after ERCP. Started Apr 2023; status: completed.
02
Drugs
amylmetacresol + 2,4-dichlorobenzyl alcohol
03
Conditions
pharyngitiscoughdysphonia
Beyond the preview
Go deeper on PACTR202409618171064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409618171064.